XML 33 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
Hedging
12 Months Ended
Dec. 31, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Hedging
Hedging

The Company’s business activities expose it to a variety of market risks, including the effects of changes in foreign currency exchange rates. The Company manages these risks through the use of forward exchange contracts, designated as foreign-currency cash flow hedges, in an attempt to reduce the potentially adverse effects of foreign currency exchange rate fluctuations that occur in the normal course of business. As such, the Company’s hedging activities are employed solely for risk management purposes. All hedging transactions are conducted with, in the opinion of management, financially stable and reputable financial institutions. As of and for the years ended December 31, 2017, 2016, and 2015 the only hedge instruments executed by the Company are associated with its exposure to fluctuations in the Indian Rupee, which result from obligations such as payroll and rent paid in this currency.

These derivatives are recognized on the balance sheet at their fair value. Unrealized gain positions are recorded as other current assets and unrealized loss positions are recorded as other current liabilities. Changes in the fair values of the outstanding derivatives that are highly effective are recorded in other comprehensive income until net income is affected by the variability of the cash flows of the hedged transaction. Hedge ineffectiveness could result when the amount of the Company’s hedge contracts exceed the Company’s forecasted or actual transactions for which the hedge contracts were designed to hedge. Once a hedge contract matures, the associated gain (loss) on the contract will remain in other comprehensive income until the underlying hedged transaction affects net income (loss), at which time the gain (loss) will be recorded to the expense line item being hedged, which is primarily within Cost of Sales, R&D and SG&A. The Company only enters into derivative contracts in order to hedge foreign currency exposure, which contracts do not exceed two years from inception. If the Company entered into a contract for speculative reasons or if the Company’s current hedge position becomes ineffective, changes in the fair values of the derivatives would be recognized in earnings in the current period.

The Company assesses, both at the inception of the hedge and on an ongoing basis, whether the derivatives that are used in hedging transactions have been highly effective in offsetting changes in the cash flows of hedged items and whether those derivatives are expected to remain highly effective in future periods. For the years ended December 31, 2017, 2016 and 2015 the Company had no hedge ineffectiveness.

During the year ended December 31, 2017, the Company entered into 18 new foreign currency forward contracts, with total contractual values of $10.5 million. During the year ended December 31, 2016, the Company entered into 45 new foreign currency forward contracts, with total contractual values of $15.4 million.

A summary of the aggregate contractual or notional amounts, balance sheet location and estimated fair values of derivative financial instruments designated as cash flow hedges at December 31, 2017 is as follows (in thousands):
 
 
Contractual / Notional
Amount
 
Consolidated Balance Sheet Classification
 
Estimated Fair Value
Asset
 
(Liability)
Foreign currency forward exchange contracts
 
$
13,018

 
Other assets
 
$
508

 
$



A summary of the aggregate contractual or notional amounts, balance sheet location and estimated fair values of derivative financial instruments designated as cash flow hedges at December 31, 2016 is as follows (in thousands):
 
 
Contractual / Notional
Amount
 
Consolidated Balance Sheet Classification
 
Estimated Fair Value
Asset
 
(Liability)
Foreign currency forward exchange contracts
 
$
16,166

 
Other assets
 
$
94

 
$


 
There were no ineffective hedges for the years ended December 31, 2017, 2016 and 2015. The following table summarizes the effect of derivative instruments on the Consolidated Statements of Operations as follows (in thousands):
 
December 31, 2017
 
December 31, 2016
 
December 31, 2015
Cost of sales
$
152

 
$
281

 
$
187

Research and development
211

 
436

 
305

Selling, general and administrative
70

 
164

 
135

Total derivative instrument expense
$
433

 
$
881

 
$
627



The following is a summary of changes to comprehensive income (loss) associated with the Company's hedging activities (in thousands):
 
For the Years Ended December 31,
 
2017
 
2016
 
2015
Beginning balance of unrealized loss on forward exchange contracts
$
(527
)
 
$
(819
)
 
$
(752
)
Other comprehensive loss before reclassifications
(83
)
 
(589
)
 
(694
)
Amounts reclassified from other comprehensive income
433

 
881

 
627

Other comprehensive income (loss)
350

 
292

 
(67
)
Ending balance of unrealized loss on forward exchange contracts
$
(177
)
 
$
(527
)
 
$
(819
)


Over the next twelve months, the Company expects to reclassify into earnings a loss of approximately $0.2 million currently recorded as other comprehensive income, as a result of the maturity of currently held forward exchange contracts.

The bank counterparties in these contracts expose the Company to credit-related losses in the event of their nonperformance. However, to mitigate that risk, the Company only contracts with counterparties who meet its minimum requirements regarding counterparty credit worthiness. In addition, the Company monitors credit ratings, credit spreads and potential downgrades prior to entering into any new hedging contracts.